Global Health vs Krishna Institute of Medical Sciences: Share Price, Comparison and Key Differences
- August 10, 2026
- Posted by: Lakshit Sharma
- Category: News
Global Health (Medanta) MCap Rs 38,720 Cr, PE 70.11x, ROE 14.05%, D/E 0.30. KIMS MCap Rs 33,930 Cr, PE 174.48x (thin earnings), ROE 10.74%, D/E 1.89.
Global Health (Medanta) vs Krishna Institute of Medical Sciences (KIMS) is a comparison hospital chain investors look up when evaluating two premium listed Indian hospital operators. Global Health operates Medanta The Medicity in Gurugram – one of India’s most recognised multi-speciality hospitals – and a growing network of Medanta hospitals in Patna, Lucknow, Ranchi and beyond. KIMS is a Hyderabad-based multi-speciality hospital group with a focus on Andhra Pradesh and Telangana – a strong position in South India’s growing corporate hospital market.
This Global Health vs Krishna Institute of Medical Sciences article covers reach and market position, key products, latest declared results and stock valuation. The Global Health vs Krishna Institute of Medical Sciences data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Global Health vs Krishna Institute of Medical Sciences: Reach and Market Position
On the Global Health side of the Global Health vs Krishna Institute of Medical Sciences comparison, Global Health operates Medanta hospitals in Gurugram (HQ), Patna, Lucknow, Ranchi and Indore, with a focus on high-end tertiary and quaternary care. Market capitalisation is Rs 38,720 Cr.
Click Here – Get Free Investment Predictions
On the Krishna Institute of Medical Sciences side of the Global Health vs Krishna Institute of Medical Sciences comparison, KIMS (Krishna Institute of Medical Sciences) operates hospitals in Hyderabad, Secunderabad, Nellore and other cities in Andhra Pradesh and Telangana, known for cardiac, neurology and orthopaedics. Market capitalisation is Rs 33,930 Cr.
Global Health vs Krishna Institute of Medical Sciences: Key Products and Business Mix
In the Global Health vs Krishna Institute of Medical Sciences product comparison, Global Health offers: Global Health earns from inpatient procedures, outpatient and diagnostics at Medanta hospitals. EPS is Rs 20.54. PE is 70.11x, ROE 14.05 percent, D/E 0.30.
For Krishna Institute of Medical Sciences in this Global Health vs Krishna Institute of Medical Sciences breakdown: KIMS earns from inpatient surgeries, medical management and OPD at its Hyderabad-region hospitals. EPS is Rs 4.63. PE is 174.48x, ROE 10.74 percent, D/E 1.89. The high PE reflects thin current earnings at KIMS as it expands capacity.
Global Health vs Krishna Institute of Medical Sciences: Latest Results
The Global Health vs Krishna Institute of Medical Sciences results for Global Health: Global Health has a market cap of Rs 38,720 Cr and PE of 70.11x. ROE is 14.05 percent. Global Health is 1.1 times larger than KIMS by market cap.
The Global Health vs Krishna Institute of Medical Sciences results for Krishna Institute of Medical Sciences: KIMS has a market cap of Rs 33,930 Cr and PE of 174.48x. ROE is 10.74 percent. The elevated PE of 174x reflects very thin current earnings while KIMS is investing in new beds and technology. D/E of 1.89 reflects hospital construction debt.
Compare Global Health and Krishna Institute of Medical Sciences Fundamentals on the Univest Screener
Global Health vs Krishna Institute of Medical Sciences: Stock and Valuation
The Global Health vs Krishna Institute of Medical Sciences stock comparison uses the latest available market data from Groww. Investors tracking Global Health vs Krishna Institute of Medical Sciences should verify current prices on NSE or BSE before trading.
Global Health vs KIMS at current valuations: Global Health trades at Rs 38,720 Cr market cap, PE 70.11x, ROE 14.05 percent. KIMS trades at Rs 33,930 Cr market cap, PE 174.48x (thin earnings), ROE 10.74 percent. Both are similarly sized. Global Health is cheaper on PE with a higher ROE. KIMS’s elevated PE prices in future capacity ramp-up.
Global Health vs Krishna Institute of Medical Sciences: Quick Comparison Table
The Global Health vs Krishna Institute of Medical Sciences comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Global Health | Krishna Institute of Medical Sciences |
|---|---|---|
| Sector | Premium multi-speciality: North India (Medanta brand) | Premium multi-speciality: South India (Hyderabad, AP) |
| Market Cap | Rs 38,720 Cr | Rs 33,930 Cr |
| P/E Ratio | 70.11x | 174.48x (thin earnings phase) |
| ROE | 14.05% | 10.74% |
| Debt to Equity | 0.30 | 1.89 (bed expansion debt) |
| Beds / Hospitals | approximately 2,500 beds across 5-6 hospitals | approximately 3,000+ beds across multiple hospitals |
| Dividend | None | None |
Conclusion
The Global Health vs Krishna Institute of Medical Sciences comparison above covers the key data points on reach, products, results and valuation. Global Health (Medanta) vs KIMS covers two premium hospital chains at different regional positions. Medanta has a strong premium North India brand and is expanding its hospital network geographically. KIMS is a trusted South India hospital brand with leadership in Hyderabad and Andhra Pradesh, currently in a capacity expansion and earnings ramp phase. Global Health vs KIMS investors should review ARPOB, occupancy rates, new bed additions, payor mix and debt service for both. Global Health vs KIMS are both credible hospital chain investments – consult a SEBI-registered advisor for personalised guidance. Global Health vs Krishna Institute of Medical Sciences investors should track bed addition timelines and payor mix shifts over the next two to three years. Global Health vs Krishna Institute of Medical Sciences both are expanding capacity in secondary Indian cities to capture growing healthcare demand. Global Health vs Krishna Institute of Medical Sciences both are classified under the healthcare services sector in Indian equity indices.
Download the Univest iOS App or Univest Android App to track Global Health and Krishna Institute of Medical Sciences live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Medanta?
Ans. Medanta The Medicity in Gurugram is India’s largest private hospital by bed count and is one of the country’s foremost destinations for cardiac surgery, neurosurgery, liver transplants and cancer care. It was founded by Dr Naresh Trehan.
What is KIMS hospital known for?
Ans. KIMS (Krishna Institute of Medical Sciences) is known for cardiac surgery, neurology, orthopaedics and trauma care in Hyderabad. It has established a strong reputation in Andhra Pradesh and Telangana.
Why is KIMS’s PE so high?
Ans. KIMS PE of 174x reflects very thin current earnings as the company is in a bed expansion and capital investment phase. New hospitals and capacity take time to reach profitable occupancy.
What is ARPOB in hospital investing?
Ans. ARPOB stands for Average Revenue Per Occupied Bed – the key efficiency metric for hospital chains measuring revenue intensity per patient.
Is Medanta expanding outside Gurugram?
Ans. Yes. Global Health is actively expanding the Medanta brand to Patna (Bihar), Lucknow (UP), Ranchi (Jharkhand) and Indore (MP), targeting underserved North and East Indian cities.
Are Global Health and KIMS in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in Nifty Healthcare and Nifty 500 indices.
Which is larger, Global Health or KIMS?
Ans. Global Health (Rs 38,720 Cr) is marginally larger than KIMS (Rs 33,930 Cr) – essentially similar in size.